American Association for Cancer Research
Browse

Related Article from Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment Breaks

Download (0.8 kB)
dataset
posted on 2023-03-31, 17:01 authored by John M.L. Ebos, Roberto Pili
Related Article from Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment Breaks

History

Related Materials

  1. 1.
    DOI - Is supplement to Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment Breaks

ARTICLE ABSTRACT

VEGF pathway inhibitors have shown benefits in many cancers, yet many (often controversial) questions remain about whether vascular and tumor regrowth can occur when therapy is stopped. Marked increases in endothelial cell proliferation could play a role in putative rebounds, potentially influencing overall efficacy, dosing schedules, and presurgical intervention strategies. Clin Cancer Res; 18(14); 3719–21. ©2012 AACR.

Usage metrics

    Clinical Cancer Research

    Categories

    Keywords

    AngiogenesisAngiogenesis inhibitors & stimulatorsGenitourinary Cancers

    Licence

    CC BY

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC